Potassium citrate

Sold as Omega kidney and bladder, Resmed mist pot cit, Propan mist pot cit simplex, Propan mist pot cit duplex, Propan mist pot cit quadruplex, Premier mist pot cit quadruplex

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 4
Registrations: 6

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
M i desatnik	Omega kidney and bladder	mixture	H1691	Not determined	None
Resmed healthcare	Resmed mist pot cit	Not stated	H1705	Not determined	None
Adcock ingram limited2 of 3 cancelled	Propan mist pot cit simplex, Propan mist pot cit duplex, Propan mist pot cit quadruplex	1,250 g	H1859, H1860, H1862	Not determined	PI PIL
The Premier Pharmaceutical Co LtdCancelled	Premier mist pot cit quadruplex	Not stated	H1878	Not determined	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Omega kidney and bladder mixture EACH 40 ml SOLUTION CONTAINS POTASSIUM CITRATE A 1920 mg	Mixture	H1691	Old Medicine	Not determined	None
Resmed mist pot cit Each liquid contains: 5 ml Potassium Citrate 1,5 g; Sodium Benzoate; Methyl Hydroxybenzoate; Propyl Hydroxybenzoate	Not listed	H1705	Old Medicine	Not determined	None
Propan mist pot cit simplex EACH 15 ml SOLUTION CONTAINS POTASSIUM CITRATE 1,25 g	1,250 gSolution.	H1859H/18.3/1859Approved 23 May 2025	Registered	Not determined	PI PIL
Propan mist pot cit duplex EACH 15 ml SOLUTION CONTAINS POTASSIUM CITRATE 2,5 g	Not listed	H1860H/18.3/1860	Cancelled	Not determined	None
Propan mist pot cit quadruplex EACH 5 ML SOLUTION CONTAINS POTASSIUM CITRATE 1,665 G	Not listed	H1862H/18.3/1862	Cancelled	Not determined	None
Premier mist pot cit quadruplex EACH 5 ml MIXTURE CONTAINS POTASSIUM CITRATE 1,665 g	Not listed	H1878H/18.3/1878	Cancelled	Not determined	None

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

S3: Potassium
- when intended for intravenous infusion or for injection;
- except when contained in oral rehydration preparations; (S0)
- except in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours. (S2)
Consolidated Schedules 06 July 2026, lines 4148 to 4153
S2: Potassium
- in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours;
- except when intended for intravenous infusion or for injection; (S3) and
- except when contained in oral rehydration preparations. (S0)
Consolidated Schedules 06 July 2026, lines 2563 to 2569

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsPropan mist pot cit simplex, Adcock ingram limited Patient information leaflet (PIL)For patients and carersPropan mist pot cit simplex, Adcock ingram limited

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background